Leticia Arruda-De Mattos

Leticia Arruda-De Mattos

Robinson Way
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications

Predictability of B cell clonal persistence and immunosurveillance in breast cancer.

Predictability of B cell clonal persistence and immunosurveillance in breast cancer.

Journal: Nature immunology
Published: February 20, 2024

Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice.

Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice.

Journal: Journal of translational medicine
Published: October 23, 2023

Converging and evolving immuno-genomic routes toward immune escape in breast cancer.

Converging and evolving immuno-genomic routes toward immune escape in breast cancer.

Journal: Nature communications
Published: August 21, 2023

ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group.

ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 21, 2022

Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation.

Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation.

Journal: The oncologist
Published: July 20, 2021

Immune analysis of lymph nodes in relation to the presence or absence of tumor infiltrating lymphocytes in triple-negative breast cancer.

Immune analysis of lymph nodes in relation to the presence or absence of tumor infiltrating lymphocytes in triple-negative breast cancer.

Journal: European journal of cancer (Oxford, England : 1990)
Published: December 10, 2020

How to use liquid biopsies to treat patients with cancer.

How to use liquid biopsies to treat patients with cancer.

Journal: ESMO open
Published: November 30, 2020

The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers.

The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers.

Journal: NPJ breast cancer
Published: September 24, 2020

PIK3CA mutation inhibition in hormone receptor-positive breast cancer: time has come.

PIK3CA mutation inhibition in hormone receptor-positive breast cancer: time has come.

Journal: ESMO open
Published: July 02, 2020

Neoantigen prediction and computational perspectives towards clinical benefit: recommendations from the ESMO Precision Medicine Working Group.

Neoantigen prediction and computational perspectives towards clinical benefit: recommendations from the ESMO Precision Medicine Working Group.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 22, 2020

New emerging targets in cancer immunotherapy: the role of neoantigens.

New emerging targets in cancer immunotherapy: the role of neoantigens.

Journal: ESMO open
Published: January 15, 2020

Integrating Biological Advances Into the Clinical Management of Breast Cancer Related Lymphedema.

Integrating Biological Advances Into the Clinical Management of Breast Cancer Related Lymphedema.

Journal: Frontiers in oncology
Published: December 02, 2019
Showing 1-12 of 58

Last Updated: 09/26/2026